Literature DB >> 24184827

Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes.

Cathy B Moelans1, Petra van der Groep2, Laurien D C Hoefnagel3, Marc J van de Vijver4, Pieter Wesseling5, Jelle Wesseling6, Elsken van der Wall7, Paul J van Diest3.   

Abstract

Cancer initiation and progression is characterized by (epi)genetic aberrations. However, little is known about the changes that occur during breast cancer metastasis. In the present study, multiplex ligation-dependent probe amplification was used to compare copy numbers of 21 established oncogenes and tumor suppressor genes between 55 primary breast cancer samples and corresponding distant metastases. Distant breast cancer metastases generally showed similar gene copy number aberrations compared to their corresponding primary tumors. The few genes that showed differences between primary tumor and metastasis (PRDM14, MED1, CCNE1, TRAF4, MTDH, CDH1) have been implicated in the development of therapy resistance.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Gene dosage; MLPA; Metastases

Mesh:

Year:  2013        PMID: 24184827     DOI: 10.1016/j.canlet.2013.10.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

Review 1.  Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.

Authors:  Lauren J Tracey; Monica J Justice
Journal:  Trends Genet       Date:  2019-05-23       Impact factor: 11.639

2.  MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy.

Authors:  Jianling Bi; Sudartip Areecheewakul; Yujun Li; Shujie Yang; Yuping Zhang; Kareem Ebeid; Long Li; Kristina W Thiel; Jun Zhang; Donghai Dai; Aliasger K Salem; Kimberly K Leslie; Xiangbing Meng
Journal:  Gynecol Oncol       Date:  2019-08-30       Impact factor: 5.482

3.  Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study.

Authors:  Janina Kulka; Borbála Székely; Lilla V Lukács; Orsolya Kiss; Anna-Mária Tőkés; Eszter Vincze; Eszter Turányi; János Fillinger; Zoltán Hanzély; Gabriella Arató; Miklós Szendrői; Balázs Győrffy; A Marcell Szász
Journal:  J Histochem Cytochem       Date:  2016-04       Impact factor: 2.479

4.  Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases.

Authors:  Willemijne A M E Schrijver; Pier Selenica; Ju Youn Lee; Charlotte K Y Ng; Kathleen A Burke; Salvatore Piscuoglio; Samuel H Berman; Jorge S Reis-Filho; Britta Weigelt; Paul J van Diest; Cathy B Moelans
Journal:  Cancer Res       Date:  2018-04-03       Impact factor: 12.701

5.  Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.

Authors:  Bin Lian; Hong Li; Yaobang Liu; Dahai Chai; Yali Gao; Yangyang Zhang; Jia Zhou; Jinping Li
Journal:  Breast Cancer       Date:  2020-10-27       Impact factor: 4.239

6.  Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast.

Authors:  Felipe Fidalgo; Tatiane Cristina Rodrigues; Mabel Pinilla; Amanda Gonçalves Silva; Maria do Socorro Maciel; Carla Rosenberg; Victor Piana de Andrade; Dirce Maria Carraro; Ana Cristina Victorino Krepischi
Journal:  Tumour Biol       Date:  2014-11-13

7.  Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics.

Authors:  Aliccia Bollig-Fischer; Sharon K Michelhaugh; Priyanga Wijesinghe; Greg Dyson; Adele Kruger; Nallasivam Palanisamy; Lydia Choi; Baraa Alosh; Rouba Ali-Fehmi; Sandeep Mittal
Journal:  Oncotarget       Date:  2015-06-10

8.  Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis.

Authors:  Anne Bruun Krøigård; Martin Jakob Larsen; Anne-Vibeke Lænkholm; Ann S Knoop; Jeanette D Jensen; Martin Bak; Jan Mollenhauer; Torben A Kruse; Mads Thomassen
Journal:  Oncotarget       Date:  2015-03-20

9.  MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.

Authors:  Cheng Du; Xiaomin Yi; Wenchao Liu; Tao Han; Zhaozhe Liu; Zhenyu Ding; Zhendong Zheng; Ying Piao; Jianlin Yuan; Yaling Han; Manjiang Xie; Xiaodong Xie
Journal:  BMC Cancer       Date:  2014-11-24       Impact factor: 4.430

10.  Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases.

Authors:  Katherine A Hoadley; Marni B Siegel; Krishna L Kanchi; Christopher A Miller; Li Ding; Wei Zhao; Xiaping He; Joel S Parker; Michael C Wendl; Robert S Fulton; Ryan T Demeter; Richard K Wilson; Lisa A Carey; Charles M Perou; Elaine R Mardis
Journal:  PLoS Med       Date:  2016-12-06       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.